A new analysis by the Organisation for Economic Co-operation and Development quantifies the macroeconomic impact of Non-Communicable Diseases (NCDs), identifying them as a major constraint on long-term growth. The report estimates that NCDs could reduce India’s GDP by nearly 4% annually by 2050, driven by their effects on labour supply, productivity, and health expenditure.
Globally, NCDs account for nearly 70% of deaths, but the economic impact varies by country depending on underlying risk factors and health system capacity. The OECD finds that targeting a single dominant risk factor can deliver up to half of the total potential health and economic gains, highlighting the importance of prioritisation.
India’s NCD landscape is particularly critical, with the nation facing a dual burden of worsening risk factors and a rising prevalence of multimorbidity. Between 1990 and 2023, diabetes prevalence in India surged by 86%, while Cardiovascular Diseases (CVD) rose by 27%.
Currently, one in eight Indians lives with CVD, and one in ten has diabetes. The OECD projects that by 2050, the number of new NCD cases in India will grow by 31%, potentially reducing annual GDP by nearly 4% on average.
Unlike OECD peers where obesity is the primary driver, India’s NCD burden is shaped by the intersection of high air pollution, smoking, and low CVD survival rates, often manifesting as multimorbidity (the presence of two or more chronic conditions in a single individual) which complicates treatment and escalates healthcare costs.
Detailed India-Specific Findings and Priorities
The GDP Impact: NCDs are not just health issues; they are economic drains. Addressing air pollution alone could boost India’s GDP by 1% and reduce healthcare spending by 4.7%.
Workforce Productivity: The top three drivers of lost workforce output in India are identified as Air Pollution, Smoking, and low CVD survival rates.
The Mortality Gap: Improving CVD survival rates could reduce premature mortality by 6%, while tackling smoking and air pollution could reduce it by 4% and 5%, respectively.
The Obesity Trend: While India has made some progress in reducing smoking rates, the report notes that obesity trends are consistently worsening, acting as a ticking time bomb for future diabetes cases.
Screening Gaps: The OECD recommends a shift from general awareness to targeted screening for high-risk populations, specifically those with a family history of CVD or those living in high-pollution urban corridors.
What is "Multimorbidity" in the NCD Context?
Multimorbidity refers to a clinical condition where an individual suffers from two or more chronic (long-term) NCDs at the same time. For example, an individual might have both diabetes and hypertension.
For India, the OECD highlights multimorbidity as a major policy challenge because treating multiple chronic conditions is exponentially more expensive than treating one. It requires a "person-centered" health system rather than one designed for single-disease episodes. If India does not strengthen its primary care to manage multimorbidity, the sheer complexity of patient care will overwhelm health budgets as the population ages.
Policy Relevance
Economic Necessity: With a projected 4% hit to GDP, tackling NCDs is a mandatory economic strategy to protect the "demographic dividend" and ensure a productive workforce.
Inter-Ministerial Action on Air Pollution: The report clarifies that the Ministry of Health cannot solve the NCD crisis alone; it requires the Ministry of Power, Transport, and Urban Planning to collaborate on air quality as a public health imperative.
Shift to Primary Prevention: Strengthening lifestyle counselling at the primary care level (focused on smoking cessation and nutrition) is proven to deliver higher returns than late-stage tertiary hospital investments.
Standardising CVD Survival: Enhancing emergency response and early detection for heart attacks can immediately lower premature mortality rates, providing a quick win for the national healthcare system.
Follow the Full Report Here:
OECD: The Health and Economic Benefits of Tackling NCDs
The Health and Economic Benefits of Tackling Non‑Communicable Diseases: India